Anti‐PD‐L1 inhibitors could bind to PD‐L1 and then inhibit the combination of PD‐1 on T cells and PD‐L1 on tumor cells,which allows immune cells to recognize and kill tumor cells. The gene discussed is CD274; the disease is neoplasm.